{"mainPropery":{"diseaseId":6450,"diseaseName":"Fish-eye disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6450/fish-eye-disease","synonyms":["FED","Dyslipoproteinemic corneal dystrophy","Alpha-lecithin cholesterol acyltransferase deficiency","ALPHA-LCAT deficiency","LCATA deficiency","Partial LCAT deficiency"],"synonyms-with-source":[{"name":"FED"},{"name":"Dyslipoproteinemic corneal dystrophy"},{"name":"Alpha-lecithin cholesterol acyltransferase deficiency"},{"name":"ALPHA-LCAT deficiency"},{"name":"LCATA deficiency"},{"name":"Partial LCAT deficiency","source":"Orphanet"}],"identifiers":[{"identifierType":"OMIM","identifierId":"136120"},{"identifierType":"ORPHANET","identifierId":"79292"},{"identifierType":"UMLS","identifierId":"C0342895"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/136120' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=omim_Detailed&db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=136120' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Fish-eye disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/fish-eye-disease' target='_blank'>Genetics Home Reference</a> contains information on Fish-eye disease. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0342895' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/122958-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79292' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:136120' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":11948,"questionText":"What is fish-eye disease?","answerText":"<strong>Fish-eye disease</strong> is a rare condition that affects the eyes. People with this condition generally develop corneal clouding beginning in adolescence or early adulthood. Overtime, the condition gradually worsens and can lead to significant vision loss. Fish-eye disease is caused by changes (mutations) in the <em><a href=\"https://ghr.nlm.nih.gov/gene/LCAT\" target=\"_blank\">LCAT</a></em> gene and is inherited in an autosomal recessive manner. Treatment is based on the signs and symptoms present in each person. In severe cases, corneal transplantation may be recommended.[13511][13512][13513]","dateModified":"2017-06-21T21:58:00"},"basicQuestions":[{"questionId":11943,"questionText":"What&nbsp;are the signs and symptoms of&nbsp;fish-eye disease?","answerText":"The signs and symptoms of fish-eye disease generally begin in adolescence or early adulthood and affect the clear front surface of the eye (also called the <a href=\"https://medlineplus.gov/ency/imagepages/9909.htm\" target=\"_blank\">cornea</a>). In people with this condition, the cornea gradually becomes cloudy. This condition often worsens overtime which can lead to significant visual impairment. Some affected people may also have signs of <a href=\"https://medlineplus.gov/atherosclerosis.html\" target=\"_blank\">atherosclerosis</a>, a condition in which plaque builds up inside the arteries.[13511][13512][13513]","dateModified":"2017-06-20T21:12:00","resourceClassificationName":"Symptoms","references":[{"referenceId":13511,"authors":"Catherine Anastasopoulou, MD, PhD, FACE","articleTitle":"Lecithin-Cholesterol Acyltransferase Deficiency","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/122958-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13512,"authors":"Dimick SM, Sallee B, Asztalos BF, Pritchard PH, Frohlich J, Schaefer EJ","articleTitle":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","bookWebsiteJournalTitle":"J Clin Lipidol","date":"March-April 2014","volume":"8(2)","pages":"223-230","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13513,"authors":"","articleTitle":"Fish-eye disease","bookWebsiteJournalTitle":"Orphanet","date":"March 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79292","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11944,"questionText":"What causes fish-eye disease?","answerText":"Fish-eye disease is caused by changes (mutations) in the <em><a href=\"https://ghr.nlm.nih.gov/gene/LCAT\" target=\"_blank\">LCAT</a></em> gene. This gene encodes an enzyme that helps remove cholesterol from the blood and certain tissues. It carries out this role by helping cholesterol attach to <a href=\"https://medlineplus.gov/ency/article/007262.htm\" target=\"_blank\">lipoproteins</a>, which carry it to the liver for redistribution to certain tissues or for removal. Fish-eye disease occurs when mutations impair the enzyme's ability to attach cholesterol to a lipoprotein called high-density lipoprotein (HDL), specifically. As a result, cholesterol begins to cloud the <a href=\"https://medlineplus.gov/ency/imagepages/9909.htm\" target=\"_blank\">cornea</a>. It is unclear why cholesterol deposits almost exclusively affect the cornea in this condition.[13515][13513]<br />\r\n<br />\r\nOf note, mutations that affect the enzyme's ability to attach cholesterol to HDL, low-density lipoprotein, and very low-density lipoprotein lead to a related disorder called <a href=\"https://rarediseases.info.nih.gov/diseases/4011/familial-lcat-deficiency\" target=\"_blank\">complete LCAT deficiency</a>, which involves corneal opacities in combination with features affecting other parts of the body.[13515]<br />","dateModified":"2017-06-20T22:12:00","resourceClassificationName":"Cause","references":[{"referenceId":13513,"authors":"","articleTitle":"Fish-eye disease","bookWebsiteJournalTitle":"Orphanet","date":"March 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79292","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13515,"authors":"","articleTitle":"fish-eye disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2013","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/fish-eye-disease#","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11945,"questionText":"Is fish-eye disease inherited?","answerText":"Fish-eye disease is inherited in an autosomal recessive manner.[13515] This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected</li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent\r\n    </li>\r\n    <li>25% chance to be unaffected and not be a carrier</li>\r\n</ul>","dateModified":"2017-06-20T22:24:00","resourceClassificationName":"Inheritance","references":[{"referenceId":13515,"authors":"","articleTitle":"fish-eye disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2013","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/fish-eye-disease#","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11946,"questionText":"How is fish-eye disease diagnosed?","answerText":"A diagnosis of fish-eye disease is first suspected based on the presence of characteristic signs and symptoms. Additional testing can then be ordered to confirm the diagnosis and rule out other conditions that can be associated with similar features. This testing may include:[13513][13511]<br />\r\n<ul>\r\n    <li>Genetic testing to identify two mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/LCAT\" target=\"_blank\">LCAT</a></em> gene. </li>\r\n    <li>Testing that analyzes the function of the enzyme encoded by the <em>LCAT</em> gene.</li>\r\n    <li>Specialized urine and blood tests.</li>\r\n</ul>","dateModified":"2017-06-21T14:40:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13511,"authors":"Catherine Anastasopoulou, MD, PhD, FACE","articleTitle":"Lecithin-Cholesterol Acyltransferase Deficiency","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/122958-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13513,"authors":"","articleTitle":"Fish-eye disease","bookWebsiteJournalTitle":"Orphanet","date":"March 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79292","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11947,"questionText":"How might fish-eye disease be treated?","answerText":"Treatments are available to help manage the signs and symptoms of fish-eye disease. Affected people will generally be followed by an ophthalmologist to monitor and treat worsening visual impairment. In severe cases, corneal transplantation may be recommended.[13513][13511] Researchers are currently studying other potential therapies. For example, one recent study suggested that statins (cholesterol-reducing medications) could be prescribed in people affected by fish-eye disease to reduce the risk of atherosclerosis.[13512]","dateModified":"2017-06-21T14:54:00","resourceClassificationName":"Treatment","references":[{"referenceId":13511,"authors":"Catherine Anastasopoulou, MD, PhD, FACE","articleTitle":"Lecithin-Cholesterol Acyltransferase Deficiency","bookWebsiteJournalTitle":"Medscape Reference","date":"August 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/122958-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13512,"authors":"Dimick SM, Sallee B, Asztalos BF, Pritchard PH, Frohlich J, Schaefer EJ","articleTitle":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","bookWebsiteJournalTitle":"J Clin Lipidol","date":"March-April 2014","volume":"8(2)","pages":"223-230","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13513,"authors":"","articleTitle":"Fish-eye disease","bookWebsiteJournalTitle":"Orphanet","date":"March 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79292","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14402,"phenoTypeName":"Corneal opacity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10925,"phenoTypeName":"Decreased HDL cholesterol concentration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9006,"phenoTypeName":"Angina pectoris","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13787,"phenoTypeName":"Atherosclerosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5614,"phenoTypeName":"Visual impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","percentRanges":"-"},{"phenoTypeId":14582,"phenoTypeName":"Increased LDL cholesterol concentration","percentRanges":"-"},{"phenoTypeId":4009,"phenoTypeName":"Increased VLDL cholesterol concentration","percentRanges":"-"},{"phenoTypeId":10585,"phenoTypeName":"Opacification of the corneal stroma","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Fish-eye_disease"}